3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Stomach Neoplasms
12
Colorectal Neoplasms
10
Adenocarcinoma
6
Breast Neoplasms
5
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Esophageal Neoplasms
4
Sarcoma
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Melanoma
2
HER2-positive Gastric Cancer
2
Gastrointestinal Neoplasms
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Interventions
Blood Specimen Collection
4
Liquid Biopsy
2
trastuzumab deruxtecan
1
tislelizumab
1
fludarabine phosphate
1
fludarabine
1
Pirinitramide
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Morphine
1
Leucovorin
1
Irinotecan
1
HMPL-013
1
Folfox protocol
1
Fluorouracil
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Analgesia, Epidural
1
AP 1903 reagent
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
trastuzumab deruxtecan
×
Gastrointestinal
×
Clear all
NCT05965479
2024-11-12
DECIPHER
University of Southampton
Phase 2
Recruiting
25 enrolled